about
Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor MasZika virus challenges for neuropsychiatryUpdate on the approach of urinary tract infection in childhoodCurrent knowledge on esophageal atresiaThe Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in ChildhoodUrinary Levels of IL-1β and GDNF in Preterm Neonates as Potential Biomarkers of Motor Development: A Prospective Study.Beneficial effects of the activation of the angiotensin-(1-7) MAS receptor in a murine model of adriamycin-induced nephropathy.Usefulness of positron emission tomography in the differentiation between tumor and infectious lesions in pediatric oncology: a case reportAngiotensin converting enzyme 2, Angiotensin-(1-7), and receptor MAS axis in the kidney.Clinical course of 822 children with prenatally detected nephrouropathiesHemostatic Parameters according to Renal Function and Time after Transplantation in Brazilian Renal Transplanted Patients.Influence of ACE I/D Polymorphism on Circulating Levels of Plasminogen Activator Inhibitor 1, D-Dimer, Ultrasensitive C-Reactive Protein and Transforming Growth Factor β1 in Patients Undergoing HemodialysisDiagnostic criteria for autoimmune hepatitis in children: a challenge for pediatric hepatologistsSuccessful management of concomitant omphalocele, accessory hepatic lobe, and biliary atresia in a 44-day-old boy.The therapeutic potential of Angiotensin-(1-7) as a novel Renin-Angiotensin System mediator.[Frequency of overweight and obesity in children and adolescents with autism and attention deficit/hyperactivity disorder].Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis.Interactions between cytokines, congenital anomalies of kidney and urinary tract and chronic kidney diseaseRelationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis.Effect of propranolol on the splanchnic and peripheral renin angiotensin system in cirrhotic patients.Renin-angiotensin system in the pathogenesis of liver fibrosis.Chemokines as potential markers in pediatric renal diseases.Hemostatic changes in patients with end stage renal disease undergoing hemodialysis.A predictive model of progression of CKD to ESRD in a predialysis pediatric interdisciplinary program.Bone disease and cytokines in idiopathic hypercalciuria: a review.The renin-angiotensin-aldosterone system in 2011: role in hypertension and chronic kidney disease.The therapeutic role of Renin-Angiotensin System blockers in obesity- related renal disorders.The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies.Congenital anomalies of the kidney and urinary tract: an embryogenetic review.The experimental model of nephrotic syndrome induced by Doxorubicin in rodents: an update.Kidney-brain axis inflammatory cross-talk: from bench to bedside.ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis.Immunoglobulin A nephropathy: a pathophysiology view.Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients.The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research.Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy.The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy.Characterization of an experimental model of progressive renal disease in rats.Anxiety, depression, resilience and quality of life in children and adolescents with pre-dialysis chronic kidney disease.Renin angiotensin system in liver diseases: Friend or foe?
P50
Q24680069-DB665AC8-E604-4C9D-927C-BB0024F2CAC0Q26250259-5907CB23-766B-4CC9-8D70-31DD43AD30A6Q26781563-D0959A3E-50BF-4054-AEBD-0D8FEC8337FAQ26849260-E4687A3A-17D6-4FB5-BA5A-1E781DBC6AF4Q28068996-84D9B5E5-E464-4A17-86B7-8CF52E2D1D61Q33695610-0454C116-4451-429D-8F4E-DFD5D444F2DEQ34770468-4B7C5127-3591-4C29-A39F-EAC514CF8A37Q35764141-D3080880-BF97-4050-859F-ED1AB996427AQ35810568-0B8E5ACE-2F57-4158-9D9E-2033630D037BQ35827295-3E9528A0-E347-4E97-8C50-28E4D6D6E1AFQ35851753-5ACDDA7B-CDCC-4D5A-9DFD-06FD78CD6B61Q35972437-B975E4A4-4C34-4BBF-B16C-88D190588238Q36214531-0B40B293-E21B-44FB-87AA-D272C058D5A1Q36287397-089789E4-BF9C-4A42-92B2-9F233B8EF511Q36486328-8B115ED1-525D-4F24-9188-A88D0677F915Q36697421-A400945D-4817-4D5C-9298-C855909D6F1DQ37098279-E9363FC7-12E0-4C95-9933-5C012334BFAEQ37162841-563635C2-2452-4418-91C2-7700D507A169Q37203406-723F28B4-34EF-4DA7-BB10-C8F8E4A1B450Q37413270-927B3D55-6AE1-48CE-8CEB-7A11D92E2FD6Q37507825-3C210400-7474-41AB-9A26-7E341B370E98Q37627006-81F43575-8A7A-4F9C-BEE2-81F5695D3416Q37640723-A74129A6-93D8-47E9-8548-1255D09C4261Q37682240-9965CDAF-519E-4B03-9D86-602B3C0ADDE4Q37935735-1458D5FE-DD9C-4E3C-936F-03E41D2C7101Q37938867-980F6105-E1B2-47DA-AAFC-B089423459EBQ38070004-6C22AEAE-6840-4715-8C18-C55C95D9A12FQ38152259-66B14CA6-7A9D-40EC-99B3-0CA660C3D064Q38270948-58AF90A1-385D-44F6-BC17-78F98687D336Q38383524-0375EFBA-B5C8-45D1-BD8A-D1502D6EE03EQ38682647-8468EB5F-BDA1-4DAF-91F7-72C9C970EA6BQ38781834-753683AC-1BC3-4F95-BE7D-E830AC73E0E5Q38879517-63772693-0F75-46D5-BF06-F017D96561AAQ38896208-30B32737-D83E-4308-A5AB-4C9E509F1296Q38911736-430B180C-9C46-4943-BA0F-E664D632EE59Q38944876-2ED05FC1-EA36-4AD9-B50E-C2F8FAD54BBEQ38994100-C937A734-E0C4-475A-B833-282772F882ADQ39095545-115402A7-AF7F-41A2-8E53-8F6FE0095E6FQ39279704-9505491F-1387-40E1-B359-388892C83952Q39360840-B23EC6D8-56F9-43DE-BCB9-DC3EFDC98183
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ana Cristina Simões E Silva
@ast
Ana Cristina Simões E Silva
@en
Ana Cristina Simões E Silva
@es
Ana Cristina Simões E Silva
@nl
Ana Cristina Simões E Silva
@pt
Ana Cristina Simões E Silva
@sl
type
label
Ana Cristina Simões E Silva
@ast
Ana Cristina Simões E Silva
@en
Ana Cristina Simões E Silva
@es
Ana Cristina Simões E Silva
@nl
Ana Cristina Simões E Silva
@pt
Ana Cristina Simões E Silva
@sl
altLabel
Silva ACS, Silva ACSE, Silva AC, Simoes e Silva, AC
@en
prefLabel
Ana Cristina Simões E Silva
@ast
Ana Cristina Simões E Silva
@en
Ana Cristina Simões E Silva
@es
Ana Cristina Simões E Silva
@nl
Ana Cristina Simões E Silva
@pt
Ana Cristina Simões E Silva
@sl
P1053
A-4409-2013
P106
P1153
6602647416
P21
P2798
P31
P3829
P496
0000-0001-9222-3882